Anti-SLC3A1 Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

Are you challenged by the complexity of studying amino acid transporters or developing targeted therapies for metabolic disorders? Creative Biolabs' Anti-SLC3A1 Recombinant Antibodies leverage advanced mammalian expression systems and epitope-specific engineering to deliver unmatched specificity and batch consistency. Engineered for a broad range of applications—from structural studies to preclinical research—our antibodies facilitate streamlined workflows and support accurate detection and functional characterization of SLC3A1 in both physiological and pathological contexts.

SLC3A1: A Critical Regulator of Amino Acid Transport

Creative Biolabs' Anti-SLC3A1 recombinant antibodies target the amino acid transporter heavy chain SLC3A1, a key subunit of the heterodimeric cystine/neutral amino acid transporter system. These antibodies are validated for high affinity and minimal cross-reactivity, supporting several detecting applications and functional inhibition studies.

Alternative Names

SLC3A1; ATRC; CSNU1; NBAT; D2H; FLJ23091; Neutral and basic amino acid transport protein; Cystinuria type 1 protein.

Background

SLC3A1 encodes a transmembrane glycoprotein essential for renal reabsorption of dibasic amino acids and cystine. Mutations in this gene are linked to cystinuria, a genetic disorder characterized by defective renal transport and urinary stone formation. Beyond its role in amino acid homeostasis, SLC3A1 overexpression is implicated in tumor metabolism and drug resistance, positioning it as a therapeutic target for metabolic and oncological research.

Anti-SLC3A1 rAb Products

Creative Biolabs provides a refined selection of anti-SLC3A1 recombinant antibodies, optimized for reliable performance across diverse experimental systems. Each antibody undergoes stringent validation to ensure reproducibility in detecting native and recombinant SLC3A1 isoforms, empowering researchers to explore its role in renal physiology, cancer biology, and rare genetic disorders.

Table.1 Representative anti-SLC3A1 recombinant antibody developed by Creative Biolabs.

Creative Quality Control

Each anti-SLC3A1 recombinant antibody undergoes rigorous multi-level quality assessment, encompassing affinity measurement by SPR, epitope characterization, and functional validation in disease-relevant models. Our protocols guarantee <5% inter-batch variability, ensuring reliability for longitudinal studies and large-scale therapeutic screening.

Customer Reviews

rAb Production

Our scalable, serum-free mammalian production platform ensures high-titer yields with native glycosylation patterns, critical for functional studies. From gene synthesis to purification, we deliver antibodies tailored to your research or therapeutic development needs.

Featured Anti-SLC3A1 Recombinant Antibody Production Platforms
Fig.5 Milligram-scale production of SLC3A1-targeting recombinant antibodies.

Fig.6 Gram-scale expression of recombinant antibodies specific for SLC3A1.

rAb Modalities

Creative Biolabs provides anti-SLC3A1 recombinant antibodies in diverse formats—including fragments, bispecific constructs, and other engineered variants—enabling broad applicability across experimental contexts.

Fig.7 Approaches for the generation of full-length recombinant antibodies specific to SLC3A1

Creative Biolabs combines decades of expertise in antibody development with cutting-edge technologies to advance your SLC3A1-focused projects. Contact our team today to explore our catalog, request custom solutions, or discuss collaborative opportunities.